EGFR and adenocarcinoma: Although in this study, the EGFR mutation rate was almost unrelated to the differentiation grade (P=0.0546), the incidence rate of EGFR mutation in patients with moderately differentiated lung adenocarcinoma was higher than patients with well differentiated adenocarcinoma (P =0.0162) (Table 3, Figure 5B).